BTBD9 Antikörper (AA 424-474)
Kurzübersicht für BTBD9 Antikörper (AA 424-474) (ABIN8120051)
Target
Alle BTBD9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 424-474
-
Verwendungszweck
- BTBD9 Antibody
-
Spezifität
- This antibody detects endogenous levels of BTBD9 at Human/Mouse/Rat
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from human BTBD9 AA range: 424-474
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB 1:500-2000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C/1 year
-
Haltbarkeit
- 12 months
-
-
- BTBD9 (BTB (POZ) Domain Containing 9 (BTBD9))
-
Andere Bezeichnung
- BTBD9
-
Hintergrund
-
Background: This locus encodes a BTB/POZ domain-containing protein. This domain is known to be involved in protein-protein interactions. Polymorphisms at this locus have been reported to be associated with susceptibility to Restless Legs Syndrome and may also be associated with Tourette Syndrome. Alternatively spliced transcript variants have been described. [provided by RefSeq, Aug 2011],
Gene Name: BTBD9 KIAA1880
Protein Name: BTBD9
-
Gen-ID
- 114781
-
UniProt
- Q96Q07
-
Pathways
- Transition Metal Ion Homeostasis
Target
-